Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 702

Results For "AI"

7089 News Found

NPPA brings 80 plus medicines under price regulation
News | March 22, 2021

NPPA brings 80 plus medicines under price regulation

NPPA also fixed retail price of 76 new drugs in the meeting dated 10th March 2021 to be launched by existing manufacturers including off-patent Anti-diabetic drugs allowing due benefit of patent expiry to the patients.


Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
News | March 18, 2021

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.


Merck brings new renewable energy to the grid through VPPA with Enel Green Power
News | March 18, 2021

Merck brings new renewable energy to the grid through VPPA with Enel Green Power

Has signed a 12-year, off-site, virtual power purchase agreement (VPPA) with Enel Green Power


LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants
News | March 17, 2021

LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants

Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.


Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO
News | March 15, 2021

Johnson & Johnson single-shot COVID-19 vaccine granted emergency use listing by WHO

The vaccine was 85 percent effective in preventing severe disease across all regions.


Govt. receives 215 applications for the 36 products under PLI scheme
News | March 13, 2021

Govt. receives 215 applications for the 36 products under PLI scheme

174 applications were received for 23 eligible products under Target Segment IV - Other Chemical Synthesis Based KSMs/ Drug Intermediates/APIs.


Altimmune expands AdCOVID manufacturing collaboration with Lonza
News | March 13, 2021

Altimmune expands AdCOVID manufacturing collaboration with Lonza

AdCOVID is a COVID-19 vaccine candidate that is administered via nasal spray.


UPM Biomedicals and CELLINK collaborates for 3D bioprinting developments
News | March 11, 2021

UPM Biomedicals and CELLINK collaborates for 3D bioprinting developments

The collaboration of two strong partners, CELLINK and UPM, builds confidence in making these treatments into an industrial and clinical standard, applied in a wider setting instead of remaining only within few hospitals.


From farm to pharmaceuticals: Traditional medicine in a phytopharma avatar
News | March 10, 2021

From farm to pharmaceuticals: Traditional medicine in a phytopharma avatar

Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.


Lupin Pharma Canada announces Partnership with Endoceutics
News | March 09, 2021

Lupin Pharma Canada announces Partnership with Endoceutics

Intrarosa will not only expand and strengthen our product portfolio into Women's Health in Canada but will cater to satisfy the unmet medical needs.